KIMBERLY EISENBACH: Open Payments
NPI 1811414295 · JOHNSTOWN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,554 in 221 payments from 39 companies in 2025. Trend: 2023 $3,452 · 2024 $4,973 · 2025 $5,554
Food & beverage: $5,554
| Company | Payments | Amount |
|---|---|---|
| TG Therapeutics, Inc. | 25 | $803 |
| ABBVIE INC. | 37 | $754 |
| Novartis Pharmaceuticals Corporation | 21 | $468 |
| Alexion Pharmaceuticals, Inc. | 9 | $258 |
| Lundbeck LLC | 8 | $255 |
| EMD Serono, Inc. | 9 | $248 |
| SK Life Science, Inc. | 8 | $212 |
| Lilly USA, LLC | 7 | $202 |
| Neurocrine BioSciences, Inc. | 2 | $192 |
| Biogen, Inc. | 9 | $191 |
Products named: BRIUMVI, KESIMPTA, QULIPTA, ULTOMIRIS, VYEPTI, BOTOX, INGREZZA, ACTHAR.
Industry payments across CO — which companies pay providers there.
